Media Highlights
NAVIGATE
News
Overview, history and upside potential: “Game-Changing Neuroprotection: Astrocyte Pharmaceuticals Breakthrough in Brain Injury Treatment” in the Venture Capital Post by David Thompson.
Company highlights, clinical progress, and military relevance: “Groton Company to Test New Treatment to Protect Brain After Injury” in the New London Day by Kimberly Drelich.
Overview of promising companies and therapeutics for concussion, “Game On for Concussion Therapies” in Genetic Engineering & Biotechnology News (GEN) by Gail Dutton.
Interview of CEO William Korinek on Vial’s First-In-Human podcast covering the science of astrocytes, drug development and the future of neuroprotection. @Apple Podcasts @Spotify
Journey from UT Lab Discovery to Phase 1 Clinical Study – “Preventing permanent brain injury after stroke” in UT Health’s Future Magazine News by Michael Seringer.
Caregiver SOS Radio interview/podcast (26 minutes): “Innovative new brain injury treatment tested in 1st human subject, may hold promise for patients with Alzheimer’s Disease with Dr. James Lechleiter and Dr. William Korinek,” with Ron Aaron and Tina Smith.
Profile of Astrocyte and results in a non-human primate (NHP) stroke model – “Groton Biotech Firm Working on Much-Needed Drug to Treat Stroke, Brain Injuries” in the New London Day by Brian Hallenbeck.
History of Astrocyte and early research at UT Health San Antonio – “Brain injury therapy advancing toward human studies” in UTHSA News by Will Samsom.
CBS News San Antonio KENS5 report: “San Antonio researchers developing brain injury treatment” by Matt Houston.
“The Race Is on for a ‘Concussion Pill’ as New NFL Season Begins” article in the Bleacher Report by Mike Tanier.
Astrocyte mentioned in StatNews article “A Pill for Concussions Remains a Brain-Busting Challenge” by Cassandra Willyard.
“To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells” article in Xconomy by David Holley.
Company Profile published by Nature Biopharma Dealmakers in the September 2015 issue dedicated to Neuroscience companies and their research.
- The full issue can be viewed here.
- The Astrocyte Pharmaceuticals profile page is here: Nature Biopharma Dealmakers – Astrocyte Pharmaceuticals Profile. Sept. 2015.
“Pursuing Concussion’s Cure” article in the Mission magazine by Will Samsom
Article by San Antonio Business Journal previewing presentation at The Health Cell’s State of the Industry event
Coverage by International Innovation in the May 20th 2014 issue (Issue 142), “A Brainy Bunch” (free registration required)
Journey from UT Lab Discovery to Phase 1 Clinical Study – “Preventing permanent brain injury after stroke” in UT Health’s Future Magazine News by Michael Seringer.
Profile of Astrocyte and results in NHP stroke model – “Groton biotech firm working on much-needed drug to treat stroke, brain injuries” in The Day by Brian Hallenbeck.
History of Astrocyte and early research at UT Health San Antonio – “Brain injury therapy advancing toward human studies” in UTHSA News by Will Samsom.
CBS News San Antonio KENS5 report: “San Antonio researchers developing brain injury treatment” by Matt Houston.
“To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells” article in Xconomy by David Holley.
Company Profile published by Nature Biopharma Dealmakers in the September 2015 issue dedicated to Neuroscience companies and their research.
- The full issue can be viewed here.
- The Astrocyte Pharmaceuticals profile page is here: Nature Biopharma Dealmakers – Astrocyte Pharmaceuticals Profile. Sept. 2015.
“Pursuing Concussion’s Cure” article in the Mission magazine by Will Samsom
Coverage by International Innovation in the May 20th 2014 issue (Issue 142), “A Brainy Bunch” (free registration required)
